Skip to main content

Page of 2 next disabled
and
  1. Article

    Open Access

    Real-world evidence of switching P2Y12 receptor–inhibiting therapies to prasugrel after PCI in patients with ACS: results from EFF-K registry

    Potent P2Y12 inhibitors are recommended for up to 12 months after percutaneous coronary intervention (PCI) in patients diagnosed with acute coronary syndrome (ACS). However, the prescription pattern is diverse in...

    Jeehoon Kang, Jung-Kyu Han, Han-Mo Yang, Kyung Woo Park in BMC Cardiovascular Disorders (2023)

  2. Article

    Open Access

    Comprehensiveness of cardiac rehabilitation program in Korea: a nation-wide survey result

    Cardiac rehabilitation (CR) is an essential component in secondary prevention of cardiovascular diseases. Current guidelines recommend that the program should be comprehensive including multidisciplinary behav...

    Jidong Sung, Chul Kim, Jae-Young Han, Sungju Jee in BMC Cardiovascular Disorders (2023)

Page of 2 next disabled